{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:46:50Z","timestamp":1785811610667,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04978-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:05:48Z","timestamp":1780059948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rapid resolution of submacular hemorrhage in neovascular age-related macular degeneration using pneumatic displacement and faricimab"],"prefix":"10.1186","volume":"26","author":[{"given":"Patrick Xiang","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua E.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirojini","family":"Sivachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"4978_CR1","doi-asserted-by":"publisher","unstructured":"Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal, subretinal hemorrhage in agerelated macular degeneration. Retina 1996;16:183\u20139. https:\/\/doi.org\/10.1097\/00006982-199616030-00001","DOI":"10.1097\/00006982-199616030-00001"},{"key":"4978_CR2","doi-asserted-by":"publisher","first-page":"e000398","DOI":"10.1136\/bmjophth-2019-000398","volume":"4","author":"S Khanna","year":"2019","unstructured":"Khanna S, Komati R, Eichenbaum DA, Hariprasad I, Ciulla TA, Hariprasad SM. Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review. BMJ Open Ophth. 2019;4:e000398. https:\/\/doi.org\/10.1136\/bmjophth-2019-000398.","journal-title":"BMJ Open Ophth"},{"key":"4978_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.ophtha.2023.04.014","volume":"130","author":"P-H Gabrielle","year":"2023","unstructured":"Gabrielle P-H, Delyfer M-N, Glacet-Bernard A, Conart JB, Uzzan J, Kodjikian L, et al. Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study. Ophthalmology. 2023;130:947\u201357. https:\/\/doi.org\/10.1016\/j.ophtha.2023.04.014.","journal-title":"Ophthalmology"},{"key":"4978_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00417-024-06695-4","volume":"263","author":"V Chaudhary","year":"2025","unstructured":"Chaudhary V, Mar F, Amador MJ, Chang A, Gibson K, Joussen AM, et al. Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2025;263:1239\u201347. https:\/\/doi.org\/10.1007\/s00417-024-06695-4.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4978_CR5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","volume":"35","author":"AM Joussen","year":"2021","unstructured":"Joussen AM, Ricci F, Paris LP, Korn C, Quezada-Ruiz C, Zarbin M. Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data. Eye. 2021;35:1305\u201316. https:\/\/doi.org\/10.1038\/s41433-020-01377-x.","journal-title":"Eye"},{"key":"4978_CR6","first-page":"1912","volume":"40","author":"A Otani","year":"1999","unstructured":"Otani A, Takagi H, Oh H, Koyama S, Matsumura M, Honda Y. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40:1912\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4978_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen S-J, Kim JE, et al. Polypoidal Choroidal Vasculopathy Ophthalmol. 2021;128:443\u201352. https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.006.","journal-title":"Polypoidal Choroidal Vasculopathy Ophthalmol"},{"key":"4978_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","volume":"399","author":"JS Heier","year":"2022","unstructured":"Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, et al. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet. 2022;399:729\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(22)00010-1.","journal-title":"Lancet"},{"key":"4978_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.13.11.13","volume":"13","author":"C Diack","year":"2024","unstructured":"Diack C, Avery RL, Cheung CMG, Csaky KG, Gibiansky L, Jaminion F, et al. Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema. Transl Vis Sci Technol. 2024;13:13. https:\/\/doi.org\/10.1167\/tvst.13.11.13.","journal-title":"Transl Vis Sci Technol"},{"key":"4978_CR10","doi-asserted-by":"publisher","first-page":"e40100","DOI":"10.7759\/cureus.40100","volume":"15","author":"AM Cheng","year":"2023","unstructured":"Cheng AM, Joshi S, Banoub RG, Saddemi J, Chalam KV. Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration. Cureus. 2023;15:e40100. https:\/\/doi.org\/10.7759\/cureus.40100.","journal-title":"Cureus"},{"key":"4978_CR11","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","volume":"98","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98:1144\u201367. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305702.","journal-title":"Br J Ophthalmol"},{"key":"4978_CR12","unstructured":"Iapoce C, Jennifer I, Lim MD. Effect of faricimab on nAMD with pigment epithelial detachments | HCPLive 2025. https:\/\/www.hcplive.com\/view\/jennifer-i-lim-md-effect-faricimab-namd-persistent-epithelial-detachments. (Accessed September 14, 2025)."},{"key":"4978_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/2474126421993664","volume":"5","author":"KD Kovacs","year":"2021","unstructured":"Kovacs KD, Gonzalez LA, Mahrous MA, Orlin A, Papakostas TD, D\u2019Amico DJ, et al. Choroidal Neovascularization and Macular Hemorrhage: Real-World Experience During the New York City COVID-19 Lockdown. J Vitreoretin Dis. 2021;5:525\u201330. https:\/\/doi.org\/10.1177\/2474126421993664.","journal-title":"J Vitreoretin Dis"},{"key":"4978_CR14","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.3390\/jcm9103088","volume":"9","author":"S Jeong","year":"2020","unstructured":"Jeong S, Park D-G, Sagong M. Management of a Submacular Hemorrhage Secondary to Age-Related Macular Degeneration: A Comparison of Three Treatment Modalities. JCM. 2020;9:3088. https:\/\/doi.org\/10.3390\/jcm9103088.","journal-title":"JCM"},{"key":"4978_CR15","doi-asserted-by":"publisher","unstructured":"Kitahashi M, Sakurai M, Yokouchi H, Kubota-Taniai M, Mitamura Y, Yamamoto S, et al. Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy. OPTH. 2014;485. https:\/\/doi.org\/10.2147\/OPTH.S55413.","DOI":"10.2147\/OPTH.S55413"},{"key":"4978_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00347-009-2004-3","volume":"107","author":"F H\u00f6hn","year":"2010","unstructured":"H\u00f6hn F, Mirshahi A, Hattenbach L-O. Kombinierte intravitreale Injektion von Bevacizumab und SF6-Gas bei AMD-assoziierter, submakul\u00e4rer H\u00e4morrhagie. Ophthalmologe. 2010;107:328\u201332. https:\/\/doi.org\/10.1007\/s00347-009-2004-3.","journal-title":"Ophthalmologe"},{"key":"4978_CR17","doi-asserted-by":"publisher","unstructured":"Ota H, Takeuchi J, Nonogaki R, Tamura K, Kominami T. Pneumatic displacement and anti-VEGF therapy for submacular hemorrhage in neovascular age-related macular degeneration: a retrospective study. JCM. 2025;14(3154). https:\/\/doi.org\/10.3390\/jcm14093154.","DOI":"10.3390\/jcm14093154"},{"key":"4978_CR18","doi-asserted-by":"publisher","first-page":"589703","DOI":"10.2147\/OPTH.S589703","volume":"20","author":"N Sivachandran","year":"2026","unstructured":"Sivachandran N, Ji PX, Khan H, Pickel L, Mojumder O, Aziz AA, et al. Visual and Anatomic Outcomes of Faricimab in Na\u00efve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis. Clin Ophthalmol. 2026;20:589703. https:\/\/doi.org\/10.2147\/OPTH.S589703.","journal-title":"Clin Ophthalmol"},{"key":"4978_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40942-025-00771-5","volume":"11","author":"J Lim","year":"2025","unstructured":"Lim J, Cho H, Ramkumar H, Adrean SD. Neovascular age-related macular degeneration complicated by large submacular hemorrhage managed with faricimab monotherapy. Int J Retina Vitreous. 2025;11:142. https:\/\/doi.org\/10.1186\/s40942-025-00771-5.","journal-title":"Int J Retina Vitreous"},{"key":"4978_CR20","doi-asserted-by":"publisher","first-page":"e002415","DOI":"10.1136\/bmjophth-2025-002415","volume":"10","author":"R Yanai","year":"2025","unstructured":"Yanai R, Murao F, Miki A, Terasaki H, Chujo S, Sakaeda Y, et al. 6-month outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration and their relationships with clinical findings: a multicentre cohort study from the J-CREST. BMJ Open Ophthalmol. 2025;10:e002415. https:\/\/doi.org\/10.1136\/bmjophth-2025-002415.","journal-title":"BMJ Open Ophthalmol"},{"key":"4978_CR21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","volume":"108","author":"L-O Hattenbach","year":"2001","unstructured":"Hattenbach L-O, Klais C, Koch FHJ, G\u00fcmbel HOC. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. 2001;108:1485\u201392. https:\/\/doi.org\/10.1016\/S0161-6420(01)00648-0.","journal-title":"Ophthalmology"},{"key":"4978_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ajo.2015.01.024","volume":"159","author":"JY Shin","year":"2015","unstructured":"Shin JY, Lee J, Byeon SH. Anti\u2013Vascular Endothelial Growth Factor With or Without Pneumatic Displacement for Submacular Hemorrhage. Am J Ophthalmol. 2015;159:904\u2013e9141. https:\/\/doi.org\/10.1016\/j.ajo.2015.01.024.","journal-title":"Am J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04978-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:30:51Z","timestamp":1785810651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04978-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4978"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04978-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. Ethics approval for this human study was waived by University of Toronto Research Ethics Board. Written informed consent was obtained from the individual for publication of the details of their medical case and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the individual for publication of the details of their medical case and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"462"}}